1
|
Lin C, Schwarzbach A, Sanz J, Montesinos P, Stiff P, Parikh S, Brunstein C, Cutler C, Lindemans CA, Hanna R, Koh LP, Jagasia MH, Valcarcel D, Maziarz RT, Keating AK, Hwang WYK, Rezvani AR, Karras NA, Fernandes JF, Rocha V, Badell I, Ram R, Schiller GJ, Volodin L, Walters MC, Hamerschlak N, Cilloni D, Frankfurt O, McGuirk JP, Kurtzberg J, Sanz G, Simantov R, Horwitz ME. Multicenter Long-Term Follow-Up of Allogeneic Hematopoietic Cell Transplantation with Omidubicel: A Pooled Analysis of Five Prospective Clinical Trials. Transplant Cell Ther 2023; 29:338.e1-338.e6. [PMID: 36775201 PMCID: PMC10149622 DOI: 10.1016/j.jtct.2023.01.031] [Citation(s) in RCA: 4] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/04/2023] [Revised: 01/30/2023] [Accepted: 01/31/2023] [Indexed: 02/12/2023]
Abstract
Omidubicel is an umbilical cord blood (UCB)-derived ex vivo-expanded cellular therapy product that has demonstrated faster engraftment and fewer infections compared with unmanipulated UCB in allogeneic hematopoietic cell transplantation. Although the early benefits of omidubicel have been established, long-term outcomes remain unknown. We report on a planned pooled analysis of 5 multicenter clinical trials including 105 patients with hematologic malignancies or sickle cell hemoglobinopathy who underwent omidubicel transplantation at 26 academic transplantation centers worldwide. With a median follow-up of 22 months (range, .3 to 122 months), the 3-year estimated overall survival and disease-free survival were 62.5% and 54.0%, respectively. With up to 10 years of follow-up, omidubicel showed durable trilineage hematopoiesis. Serial quantitative assessments of CD3+, CD4+, CD8+, CD19+, CD116+CD56+, and CD123+ immune subsets revealed median counts remaining within normal ranges through up to 8 years of follow-up. Secondary graft failure occurred in 5 patients (5%) in the first year, with no late cases reported. One case of donor-derived myeloid neoplasm was reported at 40 months post-transplantation. This was also observed in a control arm patient who received only unmanipulated UCB. Overall, omidubicel demonstrated stable trilineage hematopoiesis, immune competence, and graft durability in extended follow-up.
Collapse
Affiliation(s)
- Chenyu Lin
- Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina
| | | | - Jaime Sanz
- Hematology Department, Hospital Universitario y Polit
| | | | - Patrick Stiff
- Division of Hematology and Oncology, Loyola University Medical Center, Chicago, Illinois
| | | | - Claudio Brunstein
- Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, Minnesota; Department of Hematology and Oncology, Cleveland Clinic, Taussig Cancer Institute, Cleveland, Ohio
| | - Corey Cutler
- Division of Stem Cell Transplantation and Cellular Therapies, Dana-Farber Cancer Institute, Boston, Massachusetts
| | - Caroline A Lindemans
- Department of Pediatric Immunology, University Medical Center Utrecht, Utrecht, The Netherlands
| | - Rabi Hanna
- Department of Pediatric Hematology Oncology and Bone Marrow Transplantation, Cleveland Clinic, Cleveland, Ohio
| | - Liang Piu Koh
- Department of Hematology-Oncology, National University Cancer Institute, Singapore
| | - Madan H Jagasia
- Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, Tennessee
| | - David Valcarcel
- Department of Haematology and Haemotherapy, University Hospital Vall d'Hebron, Barcelona, Spain
| | - Richard T Maziarz
- Center for Hematologic Malignancies, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon
| | - Amy K Keating
- Blood and Marrow Transplantation, Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado
| | - William Y K Hwang
- Department of Haematology, National Cancer Centre Singapore, Singapore; Department of Haematology, Singapore General Hospital, Singapore; Cancer and Stem Cell Biology, Duke-NUS Medical School, Singapore
| | - Andrew R Rezvani
- Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, California
| | - Nicole A Karras
- Department of Pediatrics, City of Hope National Medical Center, Duarte, California
| | | | | | - Isabel Badell
- Pediatric Haematology and Stem Cell Transplantation Unit, Hospital de la Santa Creu I Sant Pau, Barcelona, Spain
| | - Ron Ram
- BMT Unit, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
| | - Gary J Schiller
- Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Los Angeles, California
| | - Leonid Volodin
- Division of Hematology and Oncology, University of Virginia, Charlottesville, Virginia
| | - Mark C Walters
- Benioff Children's Hospital, University of California San Francisco, Oakland, California
| | | | - Daniela Cilloni
- Department of Clinical and Biological Sciences, University of Turin, Turin, Italy
| | - Olga Frankfurt
- Division of Hematology and Oncology, Northwestern University, Chicago, Illinois
| | - Joseph P McGuirk
- Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas
| | - Joanne Kurtzberg
- Division of Hematology-Oncology, Department of Pediatrics, Duke University School of Medicine, Durham, North Carolina
| | - Guillermo Sanz
- Hematology Department, Hospital Universitario y Polit; Health Reserach Institute La Fe, Valencia, Spain; CIBERONC, ISCIII, Madrid, Spain
| | | | - Mitchell E Horwitz
- Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina.
| |
Collapse
|
2
|
Fernandes JF, Loncaric F, Marciniak M, Gilbert A, Smistad E, Lovstakken L, Mcleod K, Sitges M, Lamata P. Automatic measurement of LV wall thickness from 2D cardiac echocardiography. Eur Heart J Cardiovasc Imaging 2022. [DOI: 10.1093/ehjci/jeab289.150] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: Public grant(s) – EU funding. Main funding source(s): PIC from European Union"s Horizon 2020 Marie Skłodowska-Curie Actions ITN
Background
The wall thickness of the left ventricle (LV) is an important parameter in the diagnosis of hypertension and more specifically in hypertrophic cardiomyopathy. A user-dependent manual assessment of distances on 2D echocardiographic images is the current clinical gold-standard.
Purpose
The automation of LV wall thickness measurements in 2D echocardiography in order to improve robustness and reduce time of clinical reports where wall thickness is required, such as hypertrophy and the presence of Basal Septal Hypertrophy (BSH)(1).
Methods
A dataset of 4-chamber (4CH) echocardiograms on 118 patients with a diagnosis of hypertension (2) is used for this study. The images were segmented automatically (3) extracting the blood pool and the myocardium. Based on the curvature of the complete myocardial contour, the valve annular regions are removed leaving the endocardial and the epicardial walls as independent structures. The wall thickness along the myocardium is calculated as the distance from each endocardial border pixel to the closest epicardial point (see Figure 1). A high pass gaussian filter was applied to remove high frequency noise. Ultimately, the basal-to-mid septal wall thickness ratio that defines BSH (ratio ≥ 1.4) was computed as the maximal of basal-septal segment divided by minimum of mid-septal segment. In order to validate the method for BSH detection, the wall thickness septal ratio was carefully measured by a clinical expert following the guidelines (2). The statistical agreement was accessed via linear correlation and Bland-Altman analysis.
Results
The automatic assessment of LV wall thickness along the myocardium is feasible in 2D echocardiography. The septal ratio showed an excellent agreement with manual measurements (R2 = 0.94, bias=-0.01, see Figure 2), leading to a detection of BSH in n = 19 vs the n = 18 detected manually (1 false-negative and 2 false-positives). In comparison to the intra and inter-observer variabilities of 12% and 42% respectively in the manual measurement (4), the automatic method had no variability for a given image acquisition.
Conclusions
The automatic measurement of myocardial wall thickness from a 2D echocardiographic images is accurate and reproducible. The implementation of the methodology in clinical practise has the potential to improve and automate the assessment of hypertrophic cardiac conditions. Abstract Figure. Pipeline for automatic measurement of WT Abstract Figure. Agreement of BSH WT ratio
Collapse
Affiliation(s)
- JF Fernandes
- Kings College London, School of Biomedical Engineering and Imaging Sciences, London, United Kingdom of Great Britain & Northern Ireland
| | - F Loncaric
- Institute of Biomedical Research August Pi Sunyer (IDIBAPS), Barcelona, Spain
| | - M Marciniak
- Kings College London, School of Biomedical Engineering and Imaging Sciences, London, United Kingdom of Great Britain & Northern Ireland
| | - A Gilbert
- GE Healthcare, GE Vingmed Ultrasound, Horten, Norway
| | - E Smistad
- Norwegian University of Science and Technology, Department of Circulation and Medical Imaging, Trondheim, Norway
| | - L Lovstakken
- Norwegian University of Science and Technology, Department of Circulation and Medical Imaging, Trondheim, Norway
| | - K Mcleod
- GE Healthcare, GE Vingmed Ultrasound, Horten, Norway
| | - M Sitges
- Barcelona Hospital Clinic, Cardiovascular Institute, Barcelona, Spain
| | - P Lamata
- Kings College London, School of Biomedical Engineering and Imaging Sciences, London, United Kingdom of Great Britain & Northern Ireland
| |
Collapse
|
3
|
Cirilo MVSP, Martins CA, Fernandes JF, Marques LC, Cavalcante JPR, Bariani EMMB, Bariani LCO, Bariani C, Silva AMTC. SÍNDROME DE POEMS: RELATO DE CASO. Hematol Transfus Cell Ther 2021. [DOI: 10.1016/j.htct.2021.10.851] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
4
|
Martins CA, Fernandes JF, Cirilo MVSP, Marques LC, Cavalcante JPR, Bariani EMMB, Bariani LCO, Bariani C, Miranda FS, Freitas NMA. MIELOMA MÚLTIPLO COMO PRIMEIRA MANIFESTAÇÃO NEUROLÓGICA. Hematol Transfus Cell Ther 2021. [DOI: 10.1016/j.htct.2021.10.344] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
5
|
Seber A, Gomes A, Daudt LE, Fernandes JF, Darrigo-Junior LG, Siminone A, Silva CC, Hamerschlak N, Bonfim CS. OUTCOMES OF PEDIATRIC HEMATOPOIETIC STEM CELL TRANSPLANTS (HSCT) PERFORMED IN BRAZIL BETWEEN 2008 AND 2019. Hematol Transfus Cell Ther 2021. [DOI: 10.1016/j.htct.2021.10.450] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
6
|
Fernandes JF, Martins CA, Cirilo MVSP, Marques LC, Cavalcante JPR, Bariani LCO, Silva AMTC, Bariani C, Bariani EMMB. SARCOMA DE CÉLULAS DENDRÍTICAS FOLICULARES: RELATO DE CASO. Hematol Transfus Cell Ther 2021. [DOI: 10.1016/j.htct.2021.10.850] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
7
|
Loncaric F, Fernandes JF, Sitges M, Stessel B, Dubois J, Van Halem K, Herbots L, Bijnens B. Cardiac function during COVID-19 intensive care unit hospitalisation - deformation analysis and outcomes. Eur Heart J Cardiovasc Imaging 2021. [PMCID: PMC7929049 DOI: 10.1093/ehjci/jeaa356.166] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/18/2022] Open
Abstract
Funding Acknowledgements Type of funding sources: Public grant(s) – EU funding. Main funding source(s): Horizon 2020 European Commission Project H2020-MSCA-ITN-2016 Background Although the cardiac burden of COVID-19 has been demonstrated, follow-up imaging studies are scarce. The aim was to use speckle-tracking deformation imaging (STE) to prospectively assess cardiac function during intensive care unit (ICU) hospitalisation, comparing ventricular and atrial function of COVID-10 patients that died and those that were discharged. Methods In a single-centre, COVID-19 patients (n = 41) (71% male, aged 65 ± 11 years) were prospectively followed with echocardiography as part of ICU treatment. The left and right ventricles (LV, RV, respectively) were studied with STE in the 4-chamber cardiac view. The endpoint was defined as death or ICU discharge. Average values of the strain parameters from the first and final scans in the ICU, respectively, were calculated for the two outcome groups. Results Endpoint was not reached in 15% (n = 6) at the time of analysis. The remaining patients (n = 32) were 69% male, aged 66 (interquartile range (IQR) 60-72) years, and with an ICU mortality 26% (n = 9). The median spent in ICU was 24 (IQR 15-43) days. On average, echocardiography was performed three times during ICU hospitalisation, amounting to 103 examinations. The changes in cardiac strain are shown in Table 1. The change in LV longitudinal strain during ICU hospitalisation is shown in Figure 1. Conclusion Worsening of LV strain and lack of improvement of RV strain is linked to higher mortality in the ICU. The assessment of cardiac function might contain prognostic information in COVID-19 patients that are admitted to the ICU. | Patients discharged from thee OCU (n = 23) | Patients that died in the ICU (n = 9) | P value |
---|
Initial echo in the ICU | | | | LV strain, % (IQR) | 18.00 (15.6-19.95) | 14.4 (10.56-20.42) | 0.158 | RV strain, % (IQR) | 16.00 (14.70-20.05) | 15.50 (10.38-23.70) | 0.712 | Final echo before discharge | | | | LV strain, % (IQR) | 17.35 (15.13-18.98) | 13.20 (10.75-15.40) | 0.007 | RV strain, % (IQR) | 17.65 (16.83-19.60) | 15.75 (10.68-20.43) | 0.438 |
ICU - intensive care unit; IQR-inter-quartile range Abstract Figure 1 ![]()
Collapse
Affiliation(s)
- F Loncaric
- Institute of Biomedical Research August Pi Sunyer (IDIBAPS), Barcelona, Spain
| | - JF Fernandes
- King"s College London, London, United Kingdom of Great Britain & Northern Ireland
| | - M Sitges
- Hospital Clinic de Barcelona, Barcelona, Spain
| | - B Stessel
- Jessa clinic Hasselt, Hasselt, Belgium
| | - J Dubois
- Jessa clinic Hasselt, Hasselt, Belgium
| | | | - L Herbots
- Jessa clinic Hasselt, Hasselt, Belgium
| | - B Bijnens
- Institute of Biomedical Research August Pi Sunyer (IDIBAPS), Barcelona, Spain
| |
Collapse
|
8
|
Loncaric F, Marciniak M, Fernandes JF, Gilbert A, Nunno L, Mimbrero M, Tirapu L, Sanchis L, Doltra A, Fabijanovic D, Cikes M, Lamata P, Bijnens B, Sitges M. P735 Septal curvature - a novel, semi-automated parameter to aid in recognition of basal septal hypertrophy in arterial hypertension. Eur Heart J Cardiovasc Imaging 2020. [DOI: 10.1093/ehjci/jez319.404] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Funding Acknowledgements
Horizon 2020 European Commission Project MSCA-ITN-2016 (764738), Grant from Fundacio La Marató de TV3 (040310).
Background and aim
Localized basal septal hypertrophy (BSH) is a known marker of increased afterload and localized deformation impairment, and can be seen in one-fifth of patients with arterial hypertension. Although there is variability in the classification, BSH is mainly defined from ratios between several wall thickness measurements. We hypothesize that the curvature of the septum is reflective of localized hypertrophy and will be significantly increased in patients with BSH. Speckle tracking endocardial delineations of the left ventricle (LV) can be used to quantify curvature, with the potential to create a novel, semi-automatized parameter for recognition of patients with an increased impact of afterload on cardiac structure and function.
Methods
An echocardiogram was performed on a total of 149 patients with a diagnosis of long-standing hypertension, treated with at least one antihypertensive drug and on 19 healthy age and sex-matched controls. The interventricular septum thickness was measured at basal and mid-level in the parasternal long axis (PLAX) and 4-chamber (4C) views. BSH was identified from a two-part criterion: both a positive visual assessment of an abrupt change in septal thickness seen in the 4C or PLAX views and a basal to mid-septal ratio ≥ 1.4. A dedicated software for speckle tracking was used to trace the endocardial border of the LV in 4C and 3C view. In post-analysis, we quantified the maximal curvature of the antero- and inferoseptal segments from the exported myocardial contour. Curvature, measured in m-1, was defined as the reciprocal value of the radius of the circle fitted into the curve defined by three subsequent neighboring points in the myocardial contour. Curvature was considered negative if the curve was convex with respect to the LV long-axis.
Results
Using septal wall thickness measurements, 19% (n = 28) of hypertensive patients were classified as having BSH, whereas all healthy controls had normal geometry. Basal antero- and inferoseptal wall thickness was significantly increased in the BSH group, which was coupled with regional deformation impairment (basal inferoseptum, controls vs. non-BSH vs. BSH: 16.1 ± 2.33 vs. 15.14 ± 2.8 vs. 13.02 ± 2.98 %, p < 0.001). The curvature of the basal inferoseptum was significantly higher in the BSH group (controls vs. non-BSH vs BSH: -23.4 (-27.2, -10.9) vs. -28.3 (-40.2, -19.3) vs. -50.5 (-66.8, -33.9) m-1, p < 0.001) (Figure 1), with the same trend seen in the basal anteroseptum. The inferoseptal curvature showed a moderately strong correlation with the inferoseptal basal-to-mid wall thickness ratio (R = 0.527, p <0.001).
Conclusion
Increased septal curvature is an easily quantifiable, single-value, semi-automated parameter reflective of localized thickening that could easily be incorporated into the output of the LV speckle tracking workflow, possibly aiding in the recognition of hypertensive patients in need of a closer clinical follow-up.
Abstract P735 Figure 1
Collapse
Affiliation(s)
- F Loncaric
- Institute of Biomedical Research August Pi Sunyer (IDIBAPS), Barcelona, Spain
| | - M Marciniak
- Kings College London, Department of Biomedical Engineering, London, United Kingdom of Great Britain & Northern Ireland
| | - J F Fernandes
- Kings College London, Department of Biomedical Engineering, London, United Kingdom of Great Britain & Northern Ireland
| | - A Gilbert
- GE Vingmed, Ultrasound, Oslo, Norway
| | - L Nunno
- Hospital Clinic de Barcelona, Barcelona, Spain
| | - M Mimbrero
- Hospital Clinic de Barcelona, Barcelona, Spain
| | - L Tirapu
- Hospital Clinic de Barcelona, Barcelona, Spain
| | - L Sanchis
- Hospital Clinic de Barcelona, Barcelona, Spain
| | - A Doltra
- Hospital Clinic de Barcelona, Barcelona, Spain
| | - D Fabijanovic
- University Hospital Centre Zagreb, Department of cardiovascular diseases, Zagreb, Croatia
| | - M Cikes
- University Hospital Centre Zagreb, Department of cardiovascular diseases, Zagreb, Croatia
| | - P Lamata
- Kings College London, Department of Biomedical Engineering, London, United Kingdom of Great Britain & Northern Ireland
| | - B Bijnens
- Instituci?? Catalana de Recerca i Estudis Avan??ats (ICREA), Barcelona, Spain
| | - M Sitges
- Hospital Clinic de Barcelona, Barcelona, Spain
| |
Collapse
|
9
|
Loncaric F, Marciniak M, Nunno L, Fernandes JF, Mimbrero M, Tirapu L, Fabijanovic D, Sanchis L, Doltra A, Cikes M, Lamata P, Bijnens B, Sitges M. 155 Myocardial work in hypertension and mitral regurgitation- insights from non-invasive assessment of left ventricular pressure-strain relations. Eur Heart J Cardiovasc Imaging 2020. [DOI: 10.1093/ehjci/jez319.033] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Funding Acknowledgements
Horizon 2020 European Commission Project H2020-MSCA-ITN-2016 (764738), Grant from Fundacio La Marató de TV3 (040310)
Background and aim
Non-invasive left ventricular (LV) pressure estimates and speckle-tracking deformation curves can be used to quantify an index of myocardial work (MWI) which may offer insight into the early changes and work distribution in hypertension (HTN) and mitral regurgitation (MR) – cardiac diseases related to pressure and volume overload. The aim is to assess segmental strain and MW indices in patients with HTN, MR, and in healthy controls.
Methods
An echocardiogram was performed in 73 participants: 31 patients with a diagnosis of long-standing HTN with signs of LV hypertrophy, 22 patients with MR without hypertension, and 20 healthy age- and sex-matched controls. LV speckle-tracking was performed in 4C, 2C, and 3C apical views. MWI was calculated between mitral valve closing and opening. Average regional values of strain and MW indices were calculated by averaging the 4C, 3C, and 2C basal, mid, and apical segments, as based on the 18-segment model of the LV. Total MW per minute (MWI/min) was calculated by multiplying global MWI by the heart rate.
Results
LV ejection fraction and global longitudinal strain (GLS) were preserved and similar in all groups (GLS, controls vs. mild/moderate MR vs. severe MR vs. HTN: -21.28 ± 2.36 vs. -21.30 ± 1.49 vs. -20.93 ± 2.46 vs. -20.93 ± 2.46, p = 0.602). MR was classified as mild or moderate in 45% (n = 10) and severe in 55% (n = 12). A strong trend of higher global MWI (controls vs. mild/moderate MR vs. severe MR vs. HTN: 2098 ± 373 vs. 2036 ± 341 vs. 2237 ± 351 vs. 2297 ± 427 mmHg%, p = 0.171), as well as MWI/min could be noted in patients with hypertension and severe MR. Averaged regional deformation values showed a gradient increasing from base to apex in all groups, significantly more pronounced in the HTN patients. This deformation pattern was reflected in myocardial work distribution. In HTN, the basal region performed a lower percentage of total work, with the apex performing an increased workload. In the MR subgroups, the work was distributed similarly to the healthy controls Results are shown in Figure 1.
Conclusion
Non-invasive pressure strain relations offer additional information on cardiac function in HTN and MR with preserved LVEF and GLS. In HTN, MW is elevated and redistributed in the LV with an apex-to-base gradient signaling an apical compensation of basal impairment in the setting of increased afterload. Mild and moderate MR is associated with a compensated state of normal global MWI and work distribution, however, MWI/min in severe MR reveals an overall increase in workload - potentially predicting further LV remodeling in these patients over time.
Abstract 155 Figure 1
Collapse
Affiliation(s)
- F Loncaric
- Institute of Biomedical Research August Pi Sunyer (IDIBAPS), Barcelona, Spain
| | - M Marciniak
- Kings College London, Department of Biomedical Engineering, London, United Kingdom of Great Britain & Northern Ireland
| | - L Nunno
- Hospital Clinic de Barcelona, Barcelona, Spain
| | - J F Fernandes
- Kings College London, Department of Biomedical Engineering, London, United Kingdom of Great Britain & Northern Ireland
| | - M Mimbrero
- Hospital Clinic de Barcelona, Barcelona, Spain
| | - L Tirapu
- Hospital Clinic de Barcelona, Barcelona, Spain
| | - D Fabijanovic
- University Hospital Centre Zagreb, Department of cardiovascular diseases , Zagreb, Croatia
| | - L Sanchis
- Hospital Clinic de Barcelona, Barcelona, Spain
| | - A Doltra
- Hospital Clinic de Barcelona, Barcelona, Spain
| | - M Cikes
- University Hospital Centre Zagreb, Department of cardiovascular diseases , Zagreb, Croatia
| | - P Lamata
- Kings College London, Department of Biomedical Engineering, London, United Kingdom of Great Britain & Northern Ireland
| | - B Bijnens
- Instituci?? Catalana de Recerca i Estudis Avan??ats (ICREA), Barcelona, Spain
| | - M Sitges
- Hospital Clinic de Barcelona, Barcelona, Spain
| |
Collapse
|
10
|
Loncaric F, Marciniak M, Fernandes JF, Nunno L, Mimbrero M, Tirapu L, Sanchis L, Doltra A, Fabijanovic D, Cikes M, Lamata P, Bijnens B, Sitges M. P3836Myocardial work distribution in hypertensive patients with basal septal hypertrophy - a non-invasive assessment with left ventricular pressure-strain relations. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz745.0677] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background and aim
Localized basal septal hypertrophy (BSH) is a known marker of hypertension. However, the underlying functional significance of this morphologic finding is not clear. Non-invasive LV pressure estimates and speckle-tracking deformation curves can be used to quantify myocardial work (MW), which may offer insights into work distribution in increased afterload leading to better understanding of the early changes in hypertensive heart disease. The aim is to assess segmental strain and MW indices in hypertensive patients with and without BSH, as well as in healthy controls.
Methods
An echocardiogram was performed on a total of 149 patients with a diagnosis of long-standing hypertension and on 19 healthy age and sex-matched controls. The septum was measured at basal and mid-level in parasternal long-axis and four-chamber views. A two-part criterion - a positive visual assessment of an abrupt change in septal thickness seen in the 4C or PLAX view and a basal to mid-septal ratio ≥1.4 - was used to identify BSH. LV speckle-tracking was performed in 4C, 2C, and 3C views. Myocardial work index was calculated between mitral valve closing and opening. Average regional values of strain and MW indices were calculated by averaging the 4C, 3C, and 2C basal, mid, and apical segments.
Results
BSH was present in 19.2% (n=28) of the hypertensive cohort. There were no differences in LV ejection fraction or global longitudinal strain between the subgroups. The basal inferoseptum and anteroseptum were thicker in the hypertensive patients, significantly more so in the BSH subgroup, which was coupled with a proportional decrease in local deformation. Averaged regional deformation values showed a gradient increasing from base to apex in all subgroups, more pronounced in the BSH patients due to significantly impaired average basal deformation (controls vs. non-BSH vs. BSH: −18.33±1.92 vs. −17.24±2.14 vs. −15.56±2.08%, p<0.001). This deformation pattern was reflected in myocardial work distribution in hypertension, showing the basal region performing a lower percentage of global work, especially so in the BSH patients, while the apical region performed a significantly higher percentage, with a trend of further increase in the BSH subgroup (Figure 1).
Figure 1
Conclusion
Localised BSH, a structural finding in one-fifth of the hypertensive population, is related to functional impairment in regional systolic deformation and a pronounced redistribution of myocardial work during the cardiac cycle. An apex-to-base gradient in myocardial work signals an apical compensation of basal impairment in the setting of increased afterload. Clinical follow-up of patients is needed in order to assess the prognostic relevance of these findings.
Acknowledgement/Funding
Spanish Ministry of Economy and Competitiveness (TIN2014-52923-R), Fundacio La Maratό de TV3 (040310), H2020-MSCA-ITN-2016 (764738)
Collapse
Affiliation(s)
- F Loncaric
- Institute of Biomedical Research August Pi Sunyer (IDIBAPS), Barcelona, Spain
| | - M Marciniak
- Kings College London, Department of Biomedical Engineering, London, United Kingdom
| | - J F Fernandes
- Kings College London, Department of Biomedical Engineering, London, United Kingdom
| | - L Nunno
- Hospital Clinic de Barcelona, Barcelona, Spain
| | - M Mimbrero
- Hospital Clinic de Barcelona, Barcelona, Spain
| | - L Tirapu
- Hospital Clinic de Barcelona, Barcelona, Spain
| | - L Sanchis
- Hospital Clinic de Barcelona, Barcelona, Spain
| | - A Doltra
- Hospital Clinic de Barcelona, Barcelona, Spain
| | - D Fabijanovic
- University Hospital Centre Zagreb, Department of Cardiovascular Diseases, Zagreb, Croatia
| | - M Cikes
- University Hospital Centre Zagreb, Department of Cardiovascular Diseases, Zagreb, Croatia
| | - P Lamata
- Kings College London, Department of Biomedical Engineering, London, United Kingdom
| | - B Bijnens
- Instituciό Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain
| | - M Sitges
- Hospital Clinic de Barcelona, Barcelona, Spain
| |
Collapse
|
11
|
Penteado FD, Litvinov N, Sztajnbok J, Thomaz DY, dos Santos AM, Vasconcelos DM, Motta AL, Rossi F, Fernandes JF, Marques HHS, Benard G, de Almeida JN. Lomentospora prolificansfungemia in hematopoietic stem cell transplant patients: First report in South America and literature review. Transpl Infect Dis 2018; 20:e12908. [DOI: 10.1111/tid.12908] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/24/2018] [Revised: 02/28/2018] [Accepted: 03/24/2018] [Indexed: 01/25/2023]
Affiliation(s)
- Fernando D. Penteado
- Children's Institute; Hospital das Clínicas Faculdade de Medicina da Universidade de São Paulo; São Paulo Brazil
| | - Nadia Litvinov
- Children's Institute; Hospital das Clínicas Faculdade de Medicina da Universidade de São Paulo; São Paulo Brazil
| | - Jaques Sztajnbok
- Children's Institute; Hospital das Clínicas Faculdade de Medicina da Universidade de São Paulo; São Paulo Brazil
| | - Danilo Y. Thomaz
- Laboratory of Medical Mycology - LIM-53; Clinical Dermatology Division; Hospital das Clínicas da FMUSP and Instituto de Medicina Tropical; Universidade de São Paulo; São Paulo Brazil
| | - Antonio M. dos Santos
- Laboratory of Medical Mycology - LIM-53; Clinical Dermatology Division; Hospital das Clínicas da FMUSP and Instituto de Medicina Tropical; Universidade de São Paulo; São Paulo Brazil
| | - Dewton M. Vasconcelos
- Laboratory of Medical Investigation in Dermatology and Immunodeficiencies - LIM-56; Instituto de Medicina Tropical; Universidade de São Paulo; São Paulo Brazil
| | - Adriana L. Motta
- Central Laboratory Division-LIM03; Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo; São Paulo Brazil
| | - Flávia Rossi
- Central Laboratory Division-LIM03; Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo; São Paulo Brazil
| | - Juliana F. Fernandes
- Children's Institute; Hospital das Clínicas Faculdade de Medicina da Universidade de São Paulo; São Paulo Brazil
| | - Heloisa Helena S. Marques
- Children's Institute; Hospital das Clínicas Faculdade de Medicina da Universidade de São Paulo; São Paulo Brazil
| | - Gil Benard
- Laboratory of Medical Mycology - LIM-53; Clinical Dermatology Division; Hospital das Clínicas da FMUSP and Instituto de Medicina Tropical; Universidade de São Paulo; São Paulo Brazil
- Laboratory of Medical Investigation in Dermatology and Immunodeficiencies - LIM-56; Instituto de Medicina Tropical; Universidade de São Paulo; São Paulo Brazil
| | - João N. de Almeida
- Central Laboratory Division-LIM03; Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo; São Paulo Brazil
| |
Collapse
|
12
|
Güngör T, Teira P, Slatter M, Stussi G, Stepensky P, Moshous D, Vermont C, Ahmad I, Shaw PJ, Telles da Cunha JM, Schlegel PG, Hough R, Fasth A, Kentouche K, Gruhn B, Fernandes JF, Lachance S, Bredius R, Resnick IB, Belohradsky BH, Gennery A, Fischer A, Gaspar HB, Schanz U, Seger R, Rentsch K, Veys P, Haddad E, Albert MH, Hassan M. Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study. Lancet 2014; 383:436-48. [PMID: 24161820 DOI: 10.1016/s0140-6736(13)62069-3] [Citation(s) in RCA: 257] [Impact Index Per Article: 25.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/15/2023]
Abstract
BACKGROUND In chronic granulomatous disease allogeneic haemopoietic stem-cell transplantation (HSCT) in adolescents and young adults and patients with high-risk disease is complicated by graft-failure, graft-versus-host disease (GVHD), and transplant-related mortality. We examined the effect of a reduced-intensity conditioning regimen designed to enhance myeloid engraftment and reduce organ toxicity in these patients. METHODS This prospective study was done at 16 centres in ten countries worldwide. Patients aged 0-40 years with chronic granulomatous disease were assessed and enrolled at the discretion of individual centres. Reduced-intensity conditioning consisted of high-dose fludarabine (30 mg/m(2) [infants <9 kg 1·2 mg/kg]; one dose per day on days -8 to -3), serotherapy (anti-thymocyte globulin [10 mg/kg, one dose per day on days -4 to -1; or thymoglobuline 2·5 mg/kg, one dose per day on days -5 to -3]; or low-dose alemtuzumab [<1 mg/kg on days -8 to -6]), and low-dose (50-72% of myeloablative dose) or targeted busulfan administration (recommended cumulative area under the curve: 45-65 mg/L × h). Busulfan was administered mainly intravenously and exceptionally orally from days -5 to -3. Intravenous busulfan was dosed according to weight-based recommendations and was administered in most centres (ten) twice daily over 4 h. Unmanipulated bone marrow or peripheral blood stem cells from HLA-matched related-donors or HLA-9/10 or HLA-10/10 matched unrelated-donors were infused. The primary endpoints were overall survival and event-free survival (EFS), probabilities of overall survival and EFS at 2 years, incidence of acute and chronic GVHD, achievement of at least 90% myeloid donor chimerism, and incidence of graft failure after at least 6 months of follow-up. FINDINGS 56 patients (median age 12·7 years; IQR 6·8-17·3) with chronic granulomatous disease were enrolled from June 15, 2003, to Dec 15, 2012. 42 patients (75%) had high-risk features (ie, intractable infections and autoinflammation), 25 (45%) were adolescents and young adults (age 14-39 years). 21 HLA-matched related-donor and 35 HLA-matched unrelated-donor transplants were done. Median time to engraftment was 19 days (IQR 16-22) for neutrophils and 21 days (IQR 16-25) for platelets. At median follow-up of 21 months (IQR 13-35) overall survival was 93% (52 of 56) and EFS was 89% (50 of 56). The 2-year probability of overall survival was 96% (95% CI 86·46-99·09) and of EFS was 91% (79·78-96·17). Graft-failure occurred in 5% (three of 56) of patients. The cumulative incidence of acute GVHD of grade III-IV was 4% (two of 56) and of chronic graft-versus-host disease was 7% (four of 56). Stable (≥90%) myeloid donor chimerism was documented in 52 (93%) surviving patients. INTERPRETATION This reduced-intensity conditioning regimen is safe and efficacious in high-risk patients with chronic granulomatous disease. FUNDING None.
Collapse
Affiliation(s)
- Tayfun Güngör
- University Children's Hospital, Division of Blood and Marrow Transplantation, Zurich, Switzerland.
| | - Pierre Teira
- Centre de Recherche du CHU Sainte-Justine, Département de Pédiatrie, Université de Montréal, Montréal, QC, Canada
| | - Mary Slatter
- Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK
| | - Georg Stussi
- University Hospital, Division of Hematology and Blood and Marrow Transplantation, Zürich, Switzerland
| | - Polina Stepensky
- Hadassah Hebrew University Medical Center, Department of Blood and Marrow Transplantation, Jerusalem, Israel
| | - Despina Moshous
- AP-HP, Hôpital Necker Enfants Malades, Paediatric Immunology, Sorbonne Paris Cité, Université Paris Descartes, Imagine Institute, Paris, France
| | - Clementien Vermont
- Leiden University Medical Center, Department of Paediatrics, Leiden, Netherlands
| | - Imran Ahmad
- Blood and Marrow Transplantation Program, Hôpital Maisonneuve-Rosemont, Université de Montréal, Montréal, QC, Canada
| | - Peter J Shaw
- Children's Hospital, Division of Blood and Marrow Transplantation, Westmead, Sydney, NSW, Australia
| | | | - Paul G Schlegel
- University Children's Hospital, Division of Blood and Marrow Transplantation, Würzburg, Germany
| | - Rachel Hough
- University College London Hospitals NHS Foundation Trust, London, UK
| | - Anders Fasth
- Department of Pediatrics, University of Gothenburg, Gothenburg, Sweden
| | - Karim Kentouche
- Department of Paediatrics, Jena University Hospital, Jena, Germany
| | - Bernd Gruhn
- Department of Paediatrics, Jena University Hospital, Jena, Germany
| | | | - Silvy Lachance
- Blood and Marrow Transplantation Program, Hôpital Maisonneuve-Rosemont, Université de Montréal, Montréal, QC, Canada
| | - Robbert Bredius
- Leiden University Medical Center, Department of Paediatrics, Leiden, Netherlands
| | - Igor B Resnick
- Hadassah Hebrew University Medical Center, Department of Blood and Marrow Transplantation, Jerusalem, Israel
| | | | - Andrew Gennery
- Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK
| | - Alain Fischer
- AP-HP, Hôpital Necker Enfants Malades, Paediatric Immunology, Sorbonne Paris Cité, Université Paris Descartes, Imagine Institute, Paris, France
| | - H Bobby Gaspar
- Great Ormond Street Children's Hospital, Division of Blood and Marrow Transplantation, London, UK; Molecular Immunology Unit; UCL Institute of Child Health, London, UK
| | - Urs Schanz
- University Hospital, Division of Hematology and Blood and Marrow Transplantation, Zürich, Switzerland
| | - Reinhard Seger
- University Children's Hospital, Division of Blood and Marrow Transplantation, Zurich, Switzerland
| | - Katharina Rentsch
- University Hospital, Divison of Clinical Chemistry, KFC, Novum, Laboratory Medicine, Karolinska University Hospital-Huddinge Stockholm, Sweden
| | - Paul Veys
- Great Ormond Street Children's Hospital, Division of Blood and Marrow Transplantation, London, UK; Molecular Immunology Unit; UCL Institute of Child Health, London, UK
| | - Elie Haddad
- Centre de Recherche du CHU Sainte-Justine, Département de Pédiatrie, Université de Montréal, Montréal, QC, Canada
| | | | - Moustapha Hassan
- Division of Experimental Cancer Medicine, KFC, Novum, Laboratory Medicine, Karolinska University Hospital-Huddinge Stockholm, Sweden; Karolinska Institute, Stockholm, Sweden
| |
Collapse
|
13
|
Mazzucchelli JTL, Bonfim C, Castro GG, Condino-Neto AA, Costa NMX, Cunha L, Dantas EO, Dantas VM, de Moraes-Pinto MI, Fernandes JF, Goes HC, Goudouris E, Grumach AS, Guirau LMB, Kuntze G, Mallozzi MC, Monteiro FP, Moraes LSL, Nudelman V, Pinto JA, Rizzo MCV, Porto-Neto AC, Roxo-Junior P, Ruiz M, Rullo VEV, Seber A, Takano OA, Tavares FS, Toledo E, Vilela MMS, Costa-Carvalho BT. Severe combined immunodeficiency in Brazil: management, prognosis, and BCG-associated complications. J Investig Allergol Clin Immunol 2014; 24:184-191. [PMID: 25011356] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/03/2023] Open
Abstract
BACKGROUND Severe combined immunodeficiency (SCID) is one of the most severe forms of primary immunodeficiency. The objectives of this study were to analyze the diagnosis, treatment, and prognosis of SCID in Brazil and to document the impact of BCG vaccine. METHODS We actively searched for cases by contacting all Brazilian referral centers. RESULTS We contacted 23 centers and 70 patients from 65 families. Patients were born between 1996 and 2011, and 49 (70%) were male. More than half (39) of the diagnoses were made after 2006. Mean age at diagnosis declined from 9.7 to 6.1 months (P = .058) before and after 2000, respectively, and mean delay in diagnosis decreased from 7.9 to 4.2 months (P = .009). Most patients (60/70) were vaccinated with BCG before the diagnosis, 39 of 60 (65%) had complications related to BCG vaccine, and the complication was disseminated in 29 of 39 (74.3%). Less than half of the patients (30, 42.9%) underwent hematopoietic stem cell transplantation (HSCT). Half of the patients died (35, 50%), and 23 of these patients had not undergone HSCT. Disseminated BCG was the cause of death, either alone or in association with other causes, in 9 of 31 cases (29%, no data for 4 cases). CONCLUSIONS In Brazil, diagnosis of SCID has improved over the last decade, both in terms of the number of cases and age at diagnosis, although a much higher number of cases had been expected. Mortality is higher than in developed countries. Complications of BCG vaccine are an important warning sign for the presence of SCID and account for significant morbidity during disease progression.
Collapse
|
14
|
Riccetto AGL, Buzolin M, Fernandes JF, Traina F, Barjas-de-Castro MLR, Silva MTN, Oliveira JB, Vilela MM. Compound heterozygous RAG2 mutations mimicking hyper IgM syndrome. J Clin Immunol 2013; 34:7-9. [PMID: 24174341 DOI: 10.1007/s10875-013-9956-4] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/05/2013] [Accepted: 10/14/2013] [Indexed: 11/28/2022]
Affiliation(s)
- A G L Riccetto
- Department of Pediatrics, Center for Investigation in Pediatrics-CIPED, University of Campinas Medical School -Unicamp, Rua Tessalia Vieira de Camargo 126, Campinas, São Paulo, Brazil, CEP 13083-887
| | | | | | | | | | | | | | | |
Collapse
|
15
|
Rocha V, Porcher R, Fernandes JF, Filion A, Bittencourt H, Silva W, Vilela G, Zanette DL, Ferry C, Larghero J, Devergie A, Ribaud P, Skvortsova Y, Tamouza R, Gluckman E, Socie G, Zago MA. Association of drug metabolism gene polymorphisms with toxicities, graft-versus-host disease and survival after HLA-identical sibling hematopoietic stem cell transplantation for patients with leukemia. Leukemia 2008; 23:545-56. [DOI: 10.1038/leu.2008.323] [Citation(s) in RCA: 80] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|
16
|
Affiliation(s)
- Vanessa S Cunha
- Pós-Graduação Ciências Médicas, Universidade Federal do Rio Grande do Sul, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.
| | | | | | | | | |
Collapse
|
17
|
Fernandes JF, Pedro LM, Freire JP, Evangelista A, Granate MM, Cachita M, Pinto FJ, Sousa P, Lopes A, Dias NV, Fernandes RF. [Endovascular treatment of aneurysms of the descending thoracic aorta--a new therapeutic perspective]. Rev Port Cardiol 2000; 19:1029-35. [PMID: 11126106] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/18/2023] Open
Abstract
Endovascular treatment of aneurysmal disease of descending thoracic aorta and infra-renal abdominal aorta, has become an accepted technique, in selected cases due to the reduction of neurological morbidity, paraparesis or paraplegic and renal ischemia, associated with conventional surgery. The authors describe the first case performed in Portugal of a 75-year-old female with an expanding thoracic aneurysm managed by endovascular exclusion of the aneurysm with an EXCLUDER endoprosthesis, without any complications or evidence of endoleak, achieving complete exclusion of the aneurysm.
Collapse
Affiliation(s)
- J F Fernandes
- Instituto Cardiovascular de Lisboa, Complexo Hospitalar das Torres de Lisboa, Lisboa, Portugal
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
18
|
Hendrickx J, Coucke P, Dams E, Lee P, Odièvre M, Corbeel L, Fernandes JF, Willems PJ. Mutations in the phosphorylase kinase gene PHKA2 are responsible for X-linked liver glycogen storage disease. Hum Mol Genet 1995; 4:77-83. [PMID: 7711737 DOI: 10.1093/hmg/4.1.77] [Citation(s) in RCA: 29] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2023] Open
Abstract
Phosphorylase kinase (PHK) is a key enzyme in the control of glycogen breakdown. Several types of PHK deficiency have been described of which X-linked liver glycogenosis type I (XLG I) is the most common. Since the XLG I locus and the gene encoding the liver alpha-subunit gene of PHK (PHKA2) have both been localized to Xp22, PHKA2 was a candidate gene for XLG I. In this study we identified four point mutations in four unrelated XLG I patients: three mutations introduce a premature stop codon, whereas the fourth mutation abolishes a splice site consensus sequence leading to exon skipping. These findings indicate that PHKA2 is the XLG I gene.
Collapse
Affiliation(s)
- J Hendrickx
- Department of Medical Genetics, University of Antwerp, Belgium
| | | | | | | | | | | | | | | |
Collapse
|
19
|
Affiliation(s)
- J F Fernandes
- Department of Vascular Surgery, Faculty of Medicine, Hospital Santa Maria, Lisbon, Portugal
| |
Collapse
|
20
|
Fernandes JF, Pedro LM, Freire JP, Correia A, Pedro MM, Damião A, Pereira R, Alves JP, Martins C. [Prevalence of extracranial carotid occlusive disease. Non-invasive study]. ACTA MEDICA PORT 1992; 5:5-10. [PMID: 1570756] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
Abstract
Cerebrovascular disease is the most important cause of mortality and morbility in some European Countries, but the prevalence of carotid occlusive disease has not been adequately assessed. From 1985 to 1987, 1,143 patients were consecutively evaluated in the Vascular Laboratory in order to determine the presence of extracranial carotid occlusive disease. 638 (55.8%) were males and 505 (44.2%) females and mean age was 58 years (16-87). 509 had previously focal brain ischemia, ocular and/or hemispheric (Group I), 78 had assymptomatic cervical bruit (Group II), 55 non-hemispheric neurologic dysfunction (Group III) and 501 had atypical symptoms for cerebrovascular disease (Group IV). Diagnostic criteria for carotid disease: were peak frequency greater than 4.0 KHz; spectral broadening greater than 40% and late sysstolic turbulence. Global prevalence of carotid disease was 31.8% and the results in each group were: Gr. I-37.2%; Gr. II-57.7%; Gr. III-43.6%; Gr. IV-21.2%. 49% of the patients had hypertension, 22.8% dyslipidemia, 22.4% evidence of coronary disease and 13.6% had diabetes. Hypertension, diabetes, coronary disease and the coexistence of two risk factors were significantly more prevalent in the group of patients with carotid disease. These results confirm a high prevalence of carotid disease in this population, which is comparable to the one is northern european populations.
Collapse
|
21
|
Burger E, Lay WH, Hypolito LV, Fernandes JF. Trypanosoma cruzi: the fate of bloodstream trypomastigote, amastigote, metacyclic trypomastigote and epimastigote forms in the peritoneal macrophages of immune and non-immune mice in vivo. Acta Trop 1982; 39:111-22. [PMID: 6126093] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/18/2023]
Abstract
Experiments were done in vivo in order to compare the ability of Trypanosoma cruzi bloodstream trypomastigotes (BTr), amastigotes (Am), metacyclic trypomastigotes (MTr) and epimastigotes (Ep) to proliferate in the peritoneal macrophages of the following groups of A/Sn mice: actively immunized with increasing doses of living BTr (AIM); mice passively immunized with homologous immune serum (ISTM); mice passively transfused with normal homologous serum (NSTM) and normal mice (NM). Parasite load was evaluated by counting the number of infected peritoneal macrophages harvested on the 4th day after i.p. challenge with one of the forms. All four parasite stages infected NM. AIM seldom showed parasitized macrophages after challenge with any of the forms. ISTM always harboured numerous parasitized macrophages. The only form susceptible to humoral immunity was the Am.
Collapse
|
22
|
Abstract
Ambulatory calf volume plethysmography has been used to study venous insufficiency in 50 lower limbs. The results demonstrate that it is possible to determine the presence of venous insufficiency and differentiate between normal limbs, limbs with superficial venous insufficiency only, limbs with deep venous insufficiency and limbs with deep venous insufficiency and occlusion by determining the ambulatory volume change and maximum venous outflow or venous volume.
Collapse
|
23
|
Kimura E, Lay WH, Fernandes JF. Extracellular "in vitro" evolution of metacyclic trypomastigotes isolated from Trypanosoma cruzi cultures. Rev Inst Med Trop Sao Paulo 1978; 20:133-8. [PMID: 356159] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022] Open
|
24
|
Cáceres O, Fernandes JF. Glucose metabolism, growth and differentiation of Trypanocoma cruzi. Rev Bras Biol 1976; 36:397-410. [PMID: 790488] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
|
25
|
Fernandes JF. [Current status of vaccination in Chagas' disease]. Rev Bras Med 1970; 27:368-70. [PMID: 4097384] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
|
26
|
Ribeiro LV, Kimura E, Fernandes JF. Factors affecting the density of intracellular infection of tissue culture cells by Trypanosoma cruzi. Rev Bras Biol 1969; 29:295-308. [PMID: 4986521] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/13/2023]
|
27
|
|
28
|
Fernandes JF, Castellani O, Okumura M. Histopathology of the heart and muscles in mice immunized against Trypanosoma cruzi. Rev Inst Med Trop Sao Paulo 1966; 8:151-6. [PMID: 4962966] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/13/2023] Open
|
29
|
Castellani O, Fernandes JF. The effects of antipurines and antipyrimidines on the growth rate and nucleic acid synthesis in Trypanosoma cruzi. Rev Inst Med Trop Sao Paulo 1965; 7:275-82. [PMID: 5860694] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/17/2023] Open
|
30
|
|